Pascal Soriot

Executive Director & Chief Executive Officer at AstraZeneca Plc

Pascal Soriot

Pascal Soriot

Executive Director & Chief Executive Officer at AstraZeneca Plc

Overview
Career Highlights

Roche Pharmaceuticals, Inc.
Roche Holding AG
sanofi-aventis U.S. LLC

RelSci Relationships

3435

Number of Boards

7

Birthday

05/1960

Age

59

Relationships
RelSci Relationships are individuals Pascal Soriot likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer & Executive Director at AstraZeneca Plc

Relationship likelihood: Strong

President & Director at AstraZeneca AB

Relationship likelihood: Strong

Chief Executive Officer at Brambles Ltd.

Relationship likelihood: Strong

Founder at Aphrae AB

Relationship likelihood: Strong

Former President & Chief Executive Officer at Investor AB

Relationship likelihood: Strong

Chief Research Officer at Firmenich SA

Relationship likelihood: Strong

Former Chief Executive Officer & Director at Avon Products, Inc.

Relationship likelihood: Strong

Executive Director, Corporate Strategy at AstraZeneca Plc

Relationship likelihood: Strong

Group Finance Director at Old Mutual Group (UK) Ltd.

Relationship likelihood: Strong

Head, Respiratory Global Medicines, Astrazeneca & Chief Executive Officer of Pearl Therapeutics at AstraZeneca Plc

Relationship likelihood: Strong

Paths to Pascal Soriot
Potential Connections via
Relationship Science
You
Pascal Soriot
Executive Director & Chief Executive Officer at AstraZeneca Plc
Education
MBA

Founded in 1881 by the Paris Chamber of Commerce and Industry, HEC Paris specializes in education and research in management sciences. As a leading academic institution in Europe and worldwide, HEC Paris offers a complete and unique range of education programs for students and leaders. HEC Paris has a permanent faculty of 106 professors, 4,000 students and over 8,500 managers in executive education programs every year.

Doctor of Veterinary Medicine

École nationale vétérinaire d'Alfort.

Career History
Executive Director & Chief Executive Officer
2012 - Current

AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Chief Operating Officer
2010 - 2012

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

Chief Operating Officer
2010 - 2012

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Boards & Committees
Director
2009 - Prior

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Transactions
Details Hidden

AstraZeneca Plc purchases Omthera Pharmaceuticals, Inc.

Details Hidden

AstraZeneca Plc purchases Pearl Therapeutics, Inc. from 5AM Venture Management LLC, Clarus Ventures LLC, New Leaf Venture Partners LLC, Vatera Healthcare Partners

Public Holdings
Restricted data only for RelSci Professional users.
Advisors
Consultant
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pascal Soriot. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pascal Soriot's profile does not indicate a business or promotional relationship of any kind between RelSci and Pascal Soriot.